Elypta logo

Elypta

ID: 6958882

Elypta is a Stockholm-based biotechnology company focused on preventing cancer mortality through a liquid biopsy platform for detection and monitoring of the disease.

5

Funding Rounds

$56.7m

Money raised

Overview

Elypta is a Stockholm-based biotechnology company focused on preventing cancer mortality through a liquid biopsy platform for detection and monitoring of the disease.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Elypta has raised a total of $55.4m in funding over 5 rounds.

Key Insights:

  • Elypta Series A round, June 2022: $21m
  • Elypta June 2022 Series A Funding Round: $21m
  • Elypta , January 2020: $6.7m
  • Elypta January 2020 Seed Funding Round: $6.7m